Gene Therapy Linked to Rare Paraspinal Neoplasm in Study

The New England Journal of Medicine has published a report detailing an integration-associated paraspinal neoplasm observed following AAV gene therapy. This finding contributes to understanding potential long-term safety considerations and monitoring requirements for patients receiving adeno-associated virus vector-based gene therapies. It highlights the need for continued vigilance in gene therapy development.